#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kaposi's sarcoma Systemic sclerosis pulmonary Retinitis pigmentosa Ovarian cancer stage III Acute promyelocytic leukaemia Primary biliary cholangitis Glycogen storage disease type V Osteopetrosis Leiomyosarcoma metastatic Haematological malignancy Antiphospholipid syndrome Retinoblastoma Breast cancer Immunoglobulin G4 related disease Sexually transmitted disease More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Treatment Angiosarcoma metastatic Angiosarcoma metastatic – Diagnostics Rhabdomyosarcoma – Treatment IgA nephropathy Pulmonary fibrosis – Treatment Mucopolysaccharidosis – Basic Information Hepatic angiosarcoma – Trials in Disease Hereditary ataxia Ornithine transcarbamoylase deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zidovudine Foscarnet Maribavir Protein S Leflunomide LY3841136 SODIUM Pelareorep Pentixafor Gallium Ga-68 Propylene Glycol Hydrocortisone Acetate Efgartigimod Alfa Petrelintide Radiprodil Human Fibrinogen Pramlintide Acetate Lysine Aspirin Vorinostat RP2 Mr0005 Revumenib More therapies…

    Learn about Your Condition

    Burkitt's lymphoma CDKL5 deficiency disorder Anaemia of pregnancy Pouchitis Blood iron increased B-cell lymphoma recurrent Craniopharyngioma Caesarean section Genital infection female Von Hippel-Lindau disease Metabolic surgery Left ventricular failure Astrocytoma malignant Hyperglycaemia Procedural pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Dobutamine and Levosimendan in Patients with Heart Failure and Reduced Left Ventricular Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Left ventricular failure
    • Cardiac failure
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Levosimendan
    Spain

  • Study on Stopping Nilotinib for Chronic Myeloid Leukemia Patients After Previous Unsuccessful Attempts to Stop Tyrosine Kinase Inhibitors

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia (in remission)
    Investigated Drugs:
    • Nilotinib
    Germany

  • Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Lenalidomide
    Iceland

  • Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Alectinib
    Italy

  • Study on Allogeneic Faecal Microbiota for Treating Antibiotic-Related Diarrhea in Critically Ill Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diarrhoea
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Czechia

  • Study on Treosulfan and Melphalan for High-Risk Ewing Sarcoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Treosulfan
    • Ifosfamide
    • Vinorelbine
    Italy
Previous Page
1 … 841 842 843 844 845 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!